Transcript
Page 1: Peer Review for Paediatric Diabetes

Peer Review for Paediatric DiabetesRuth Bridgeman

Page 2: Peer Review for Paediatric Diabetes

The New Health EnvironmentThe New Health Environment

Page 3: Peer Review for Paediatric Diabetes

Benefits of Peer ReviewBenefits of Peer Review

• Provision of disease specific information across the country together with information about individual teams which has been externally validated

• Provision of benchmark data

• Provision of a catalyst for change and service improvement

• Identification and resolution of immediate risks to patients and or staff

• Engagement of a substantial number of front line clinicians in reviews

Page 4: Peer Review for Paediatric Diabetes

Benefits of Peer ReviewBenefits of Peer Review

• Clinical support for a peer review

• Enabled rapid sharing of learning between clinicians, as well as a better understanding of :

– Commissioning Services for Children and Young People with Diabetes– Delivering the Diabetes National Service Framework

Page 5: Peer Review for Paediatric Diabetes

MeasuresMeasures

Methodology – Developed by a small expert group– Fiona Campbell / Philip Holland– Ian Manifold, Ruth Bridgeman and James Heasman

Developmental – Unlikely to achieve 100% in the first round of review– Opportunity to test with the pilot– Looking to share good practice

Organisational Approach– Network Level– Hospital Level– MDT Level

Page 6: Peer Review for Paediatric Diabetes

MeasuresMeasures

D11-1A-100– CYPDN MEASURESMeasureNumber

 

D11-1A-101 Chair of the CYPDND11-1A-102 Membership and terms of reference of the CYPDND11-1A-103 CYPDN MeetingsD11-1A-104 CYPDN Annual ReportD11-1A-105 CYPDN proposals for service developmentD11-1A-106 The Configuration of MDTs within the CYPDND11-1A-107 Clinical GuidelinesD11-1A-108 Agreed Network wide diabetes minimum dataset (MDS)D11-1A-109 Children and Young People Diabetes Network review of

progress against diabetes auditD11-1A-110 Twenty-four hour telephone service specification

Page 7: Peer Review for Paediatric Diabetes

MeasuresMeasuresD11-1D-100–HOSPITAL MEASURES FOR CHILDREN AND YOUNG PEOPLE DIABETES SERVICES

MeasureNumber

 

D11-1D-101Children and Young People diabetes service specification for patient access

D11-1D-102 Minimum consultation periodD11-1D-103 Availability of information in an Outpatient environmentD11-1D-104 Availability of ICU/HDUD11-1D-105

Review of Children and Young People admissions on a quarterly basis

Page 8: Peer Review for Paediatric Diabetes

MeasuresMeasuresD11-2A-100–CHILDREN AND YOUNG PEOPLE DIABETES MDT MEASURES

MeasureNumber

 

D11-2A-101 Lead Clinician and ResponsibilitiesD11-2A-102 CYPDN AttendanceD11-2A-103 CYPD MDT Core Team MembershipD11-2A-104 Extended team membershipD11-2A-105 Policy for patients to be discussed by the CYPD MDTD11-2A-106 Treatment planning meetingD11-2A-107 Cover arrangements for core membersD11-2A-108 Operational policy meetingD11-2A-109 Informing the GP of the diagnosis and initial prescribingD11-2A-110 Key worker policyD11-2A-111 Specialist training for core nurse memberD11-2A-112 List of responsibilities for core nurse membersD11-2A-113 Access to core CYPD MDT members for follow-up patientsD11-2A-114 Patients’ permanent consultation recordD11-2A-115 Patients’ experience exerciseD11-2A-116 Outcome of patients’ experience exerciseD11-2A-117 Provision of patient written informationD11-2A-118 Clinical guidelinesD11-2A-119 Policy for the management of patients whose HBA1c rating is greater than 9.5.D11-2A-120 Policy for the screening of children and young people with type 1 diabetesD11-2A-121 Policy for patient choice of insulin pump therapyD11-2A-122 Teaching of the principles of carbohydrate countingD11-2A-123 Training policy for new patientsD11-2A-124 Management transfer of young people to young adults clinicD11-2A-125 Data collectionD11-2A-126 Participation in auditD11-2A-127 Presentation and review of audit activity

Page 9: Peer Review for Paediatric Diabetes

HandbookHandbook

• This is the key document

• Explains the processes to be used for the pilot

Page 10: Peer Review for Paediatric Diabetes

Visit ProgrammeVisit Programme

Agree Pilot Visits – Network Visit– Calderdale– Bradford – Hull

Agree Dates– 28 March – Hull– 29 March – Calderdale– 30 March – Bradford– Network Visit to be confirmed

Page 11: Peer Review for Paediatric Diabetes

Visit ProgrammeVisit Programme• Letter’s to confirm visit to go the CEOs

• Self Assessment deadlines18 March 2011

• Pre visits1st 2nd 3nd March – if requested

• Visits–28 March – Hull–29 March – Calderdale–30 March – Bradford–Network Visit to be confirmed

Page 12: Peer Review for Paediatric Diabetes

Evaluation of the pilot Evaluation of the pilot ProgrammeProgramme• Report by the Quality Manager

– Details of the outcomes of the pilot– Evaluation of the pilot– Recommended next steps


Recommended